Clinical Trials Directory

Trials / Conditions / Advanced Malignant Mesothelioma

Advanced Malignant Mesothelioma

14 registered clinical trials studyying Advanced Malignant Mesothelioma.

StatusTrialSponsorPhase
UnknownHMPL-453 in Advanced Malignant Mesothelioma
NCT04290325
Hutchison Medipharma LimitedPhase 2
WithdrawnCryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body
NCT01325753
Wake Forest University Health SciencesN/A
CompletedQuality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
NCT01126346
Wake Forest University Health SciencesN/A
WithdrawnAMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma
NCT01105390
National Cancer Institute (NCI)Phase 2
CompletedPazopanib in Treating Patients With Malignant Pleural Mesothelioma
NCT00459862
National Cancer Institute (NCI)Phase 2
CompletedSunitinib in Treating Patients With Advanced Malignant Pleural Mesothelioma
NCT00392444
National Cancer Institute (NCI)Phase 2
CompletedPXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Rem
NCT00365053
National Cancer Institute (NCI)Phase 2
CompletedCediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery
NCT00309946
National Cancer Institute (NCI)Phase 2
CompletedS0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery
NCT00243074
National Cancer Institute (NCI)Phase 2
CompletedErlotinib in Treating Patients With Malignant Mesothelioma of the Lung
NCT00039182
National Cancer Institute (NCI)Phase 2
CompletedErlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
NCT00030498
National Cancer Institute (NCI)Phase 1
TerminatedEF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for
NCT00028782
National Cancer Institute (NCI)N/A
CompletedCombination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
NCT00027703
National Cancer Institute (NCI)Phase 2
CompletedGefitinib in Treating Patients With Malignant Mesothelioma
NCT00025207
National Cancer Institute (NCI)Phase 2